GlassScriptPhysician profile
Stephen Little
NPI 1780658674
$522.56
in general payments reported to CMS, 2019-2025
15 companies · $18.52 in 2025
The $18.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $64.69 · 2022: $110 · 2023: $127 · 2024: $66.37 · 2025: $18.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $90.28 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $85.65 | 2020-2023 | |
| Allergan, INC. | $66.59 | 2019-2020 | |
| Pfizer INC. | $42.91 | 2022-2023 | |
| Smith+Nephew, INC. | $37.08 | 2019 | |
| Novo Nordisk INC | $26.04 | 2019 | |
| Hologic Sales and Service, LLC | $25.59 | 2023 | Acessa Provu System |
| Mayne Pharma Commercial LLC | $22.81 | 2022 | |
| Roche Diagnostics Corporation | $20.83 | 2020 | |
| Coopersurgical, INC. | $20.69 | 2023 | Paragard T 380a |
| Optumhealth Care Solutions, LLC | $19.96 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Millicent US INC | $18.52 | 2025 | Intrarosa, Femlyv |
| Lilly USA, LLC | $17.83 | 2024 | Zepbound |
| Myovant Sciences INC. | $15.88 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.